CarsonAllaria Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.75K | Hold |
530
| – | – | ﹤0.01% | 288 |
|
|
2025
Q1 | $3.98K | Hold |
530
| – | – | ﹤0.01% | 302 |
|
|
2024
Q4 | $3.99K | Hold |
530
| – | – | ﹤0.01% | 293 |
|
|
2024
Q3 | $4.03K | Buy |
530
+300
| +130% | +$2.28K | ﹤0.01% | 315 |
|
|
2024
Q2 | $1.42K | Hold |
230
| – | – | ﹤0.01% | 337 |
|
|
2024
Q1 | $1.17K | Hold |
230
| – | – | ﹤0.01% | 362 |
|
|
2023
Q4 | $1.38K | Hold |
230
| – | – | ﹤0.01% | 320 |
|
|
2023
Q3 | $1.63K | Sell |
230
-125
| -35% | -$885 | ﹤0.01% | 313 |
|
|
2023
Q2 | $2.5K | Buy |
355
+125
| +54% | +$880 | ﹤0.01% | 303 |
|
|
2023
Q1 | $1.92K | Hold |
230
| – | – | ﹤0.01% | 303 |
|
|
2022
Q4 | $3K | Hold |
230
| – | – | ﹤0.01% | 258 |
|
|
2022
Q3 | $3K | Hold |
230
| – | – | ﹤0.01% | 255 |
|
|
2022
Q2 | $2K | Hold |
230
| – | – | ﹤0.01% | 276 |
|
|
2022
Q1 | $4K | Hold |
230
| – | – | ﹤0.01% | 256 |
|
|
2021
Q4 | $3K | Buy |
+230
| New | +$3K | ﹤0.01% | 295 |
|